Favourable Long-Term Outcomes in Stage II/III TNBC With Atezolizumab Added to Chemotherapy, ctDNA Dynamics Provide Prognostic Value Beyond pCR By Ogkologos - July 28, 2025 532 0 Facebook Twitter Google+ Pinterest WhatsApp Final results from the IMpassion031 study Source RELATED ARTICLESMORE FROM AUTHOR Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer Patient Guide on Bone Health in Cancer Now Available Also in French Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off MOST POPULAR FDA Approves Azacitidine Tablets for Acute Myeloid Leukaemia September 4, 2020 I Received the COVID-19 Vaccine – Now What? February 8, 2021 Some People with Rectal Cancer Can Skip Radiation Before Surgery July 19, 2023 How I Navigated Being a Young Mom During Cancer: A Survivor’s... February 15, 2023 Load more HOT NEWS A Vaccine to Treat Non-Hodgkin Lymphoma Advancing in Clinical Trials Could Bacteria Help Find Cancer? Progress in Treating Liver Cancer and Biliary Tract Cancer with Immunotherapy:... Terminally Ill ‘Flamingo Lady’ Gets Emotional After Dying Wish Comes True
